Remedium Lifecare Ltd

Remedium Lifecare Stock View

(BSE)

139.15

50.09
Proj. ROE (%)
-
Proj. P/E (x)
-
Proj EV / EBITDA (x)
-
Proj. P/BV (x)
-
Proj. Revenue ( Cr.)
-

Stock View

-
Share on
The average score for Remedium Lifecare Ltd stands at against , three months back.

Remedium Lifecare Ltd. is an India-based pharmaceutical company. The Company is engaged in the business of trading application programming interfaces (APIs) intermediates and various other raw materials used in API trading, such as amino isophthalic acid, tellurium (IV) oxide, Grignard reagent, lodine, Selenium Metal Powder, trimethyl sulfoxonium lodide (TMSI). The Company operates through two business verticals: Products and Services. Products business comprises trading and sale of APIs and intermediates to innovator and generic pharmaceutical players in both domestic and international markets including the regulated markets. The Company's products include atorvastatin calcium (amorphous), atorvastatin calcium (crystalline), citalopram hydrochloride, montelukast sodium, and cetirizine dihydrochloride, levocetirizine dihydrochloride, pantoprazole sodium ambroxol hydrochloride, losartan potassium, phenylephrine, phenylephrine hydrochloride, lisinopril dihydrate, and lisinopril.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
138.82
100 DMA ()
138.19
200 DMA ()
137.86
52 Weeks Range
130.00
165.15
Street View :-
Bearish
Open ZERO Brokerage Demat Account
Open Demat Account

Invest wise with Expert advice

By continuing, I accept the Terms & Conditions and agree to receive updates on Whatsapp